Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

SpA · English

Clinical perspective

Spondyloarthritis

Use the family concept to recognise connections, then return to the specific phenotype, evidence and decision. Classification, diagnosis and treatment eligibility are distinct tasks.

Olga Goodman, MD · Evidence checked: 25 September 2026

01 · Clinical review

Diagnosis & classification

Use criteria in their intended population and preserve the uncertainty in each input. A calculated classification result is not an individual diagnostic probability.

Read clinical review →

02 · Clinical review

Imaging in context

An imaging label gains meaning from the lesion definition, acquisition quality, distribution and clinical setting. Avoid translating a single finding directly into a diagnosis.

Read clinical review →

03 · Clinical review

Treatment across domains

Choose a strategy for the active phenotype and the whole person. Evidence for one domain, a guideline recommendation and a local authorised indication are not interchangeable.

Read clinical review →

Clinical collection · English · Professional reading

Radiographic axial spondyloarthritis

Independent clinical articles on diagnostic reasoning, sacroiliac grading, MRI and CT, disease activity, treatment selection, nonresponse, tapering and the vulnerable ankylosed spine.

Explore the r-axSpA clinical collection →

Disease-specific clinical collection · EN

Reactive arthritis

From the first hot joint after infection to persistent disease: diagnostic reasoning, infection care, the antibiotic controversy and a treatment evidence map. Includes clinical decision scenarios and patient explanations in four languages.

Explore the reactive arthritis clinical module →

Disease-specific clinical collection · EN

IBD-associated spondyloarthritis

Professional Essentials and clinical chapters on finding disease in both directions, choosing therapy across organs and assessing discordant responses.

Open Essentials and demos · Treatment matrix with Professional access

Explore the IBD-associated SpA clinical collection →

Disease-specific clinical collection · EN

Juvenile-onset spondyloarthritis

Professional Essentials, classification boundaries and juvenile-onset disease in adult care: reconstructing the childhood history and keeping transition continuous.

Open Essentials · Two open clinical chapters

Explore the juvenile SpA clinical collection →

Core principles across the SpA family

Two maps, four clinical statements

Describe the named disease or associated context separately from the active musculoskeletal and extra-musculoskeletal domains. Add the degree of diagnostic confidence and distinguish current inflammation from damage and other symptom generators. ‘PsA with peripheral synovitis, dactylitis and suspected axial involvement’ is more informative than placing PsA entirely under peripheral SpA. ‘Non-radiographic’ is an imaging category, not a measure of impact or a mandatory stage in a linear progression.

Shared pathways do not imply interchangeable treatment

Enthesis-related pathology, synovitis, osteitis and bone remodelling connect these disorders, with contributions from genetic susceptibility, biomechanical factors and immune pathways. The TNF/IL-17/IL-23 framework is useful but incomplete. Biological plausibility and efficacy in skin or peripheral PsA do not establish efficacy in established axial SpA. Use clinical trial populations and domain-specific outcomes to test mechanistic assumptions.

Keep axial PsA visible

PsA may have axial involvement, peripheral involvement or both. Definitions, imaging patterns and ascertainment remain important sources of heterogeneity. The international AXIS study is relevant to phenotype description; it is not permission to replace clinical assessment with the ASAS axial classification algorithm in every patient with psoriasis and back pain. Check whether evidence concerns axSpA with psoriasis, axial PsA or a post hoc subgroup defined by symptoms.

Assess what remains active

For axSpA, ASDAS provides a disease-activity framework with clinical assessment; BASDAI captures patient-reported burden but is not an objective inflammation test. For PsA, joint-focused instruments such as DAPSA do not fully represent skin, enthesitis, dactylitis or axial disease. Minimal disease activity is a multidomain state, yet individual domains still need inspection. Persistent symptoms require evaluation of inflammation, structural limitation, adherence, comorbidity and pain mechanisms.

Three short reasoning prompts

A patient with psoriasis and heel tenderness needs assessment for enthesitis and mechanical explanations before the skin diagnosis is used as an anchor. A patient with established axSpA and high pain despite a stable examination needs a search for active disease and additional contributors before escalation. A patient with bowel remission and inflammatory axial symptoms still requires an axial assessment; control of one organ does not establish control of another.

Interactive explorer · EN

Classification Explorer

Explore the family map, criteria and sacroiliitis grading. Professional tool in English.

Open full window ↗

Select a section inside the tool to explore. Classification criteria do not establish an individual diagnosis.

CASCADE · Professional learning · EN

From IL-23 biology to a defensible treatment plan

Explore the receptor mechanism, distinguish psoriasis evidence from PsA evidence, and work through George’s uncertain joint symptoms.

Patient education

Clear explanations to share

Shared features, diagnosis, treatment and daily life, with a direct route into each language.

Sources & further reading
  1. ASAS consensus on the nomenclature of axial spondyloarthritis (2024)
  2. ASAS–EULAR axSpA management recommendations: 2022 update
  3. EULAR PsA pharmacological recommendations: 2023 update, published 2024
  4. GRAPPA treatment recommendations 2021, published 2022
  5. International AXIS study: axial involvement in PsA (2026)
  6. EULAR recommendations for fatigue in inflammatory rheumatic diseases (2023)

Interactive clinical reasoning · English

nr-axSpA · Professional quizzes

Apply the clinical chapter to diagnosis, imaging, prognosis, treatment and evidence. Quiz descriptions are open. Quizzes marked Open demo are available without an account; other full quizzes require professional access.

Below the Line Is Not “Early”

Radiographic category, symptom duration and disease burden.

Explore the quiz →

A Referral Is Not a Verdict

Inflammatory back pain, HLA-B27, CRP and a reviewable working diagnosis.

Explore the quiz →

Name the Joint, Name the Sequence

Dedicated SIJ MRI, structural lesions, reporting and the medication context.

Explore the quiz →

Bright, but Whose?

Postpartum and loading changes, OCI, fracture and infection on SIJ MRI.

Explore the quiz →

Progression Is One Outcome

Cohort denominators, risk factors and remission without an invented personal percentage.

Explore the quiz →

Two NSAIDs Are a Trial, Not a Sentence

NSAID trials, objective inflammation and the move to advanced therapy.

Explore the quiz →

The Eye and the Gut Choose First

Uveitis, IBD, response assessment and a reasoned treatment switch.

Explore the quiz →

Change Is Not State

ASDAS response versus disease state, monitoring and tapering.

Explore the quiz →

Plan Before the Positive Test

Conception, pregnancy, postpartum care and the infant’s vaccine plan.

Explore the quiz →

Read the Entry Criteria

Trial populations, endpoints, cross-trial comparisons and JAK safety.

Explore the quiz →

Open demo

Two Pains, One Patient

When the score stays high and the inflammation does not.

Explore the quiz →

Bridging Is a Shape

Spinal findings, CT and anatomy: ask the structural question before the next scan.

Explore the quiz →

Open demo

Now, Not Next Month

Safety boundaries in a patient who already has a diagnosis.

Explore the quiz →

Write It So It Can Be Revised

Requests, reports and assessments that the next clinician can actually use.

Explore the quiz →

Remission — Which Kind?

Feeling well, low activity, remission on treatment and after it: four different statements.

Explore the quiz →

Open demo

A Difference Is Not a Test

Anti-CD74, genetic susceptibility, response signatures and the intended use of a biomarker.

Open the demo quiz →

A Precise Number Is Not a Validated One

Faster MRI, synthetic CT, AI validation, flare prediction and the limits of a precise probability.

Explore the quiz →

Open demo

Promising Is Not Proven

Sonelokimab, ERAP1, negative trials and the evidence needed before adopting an innovation.

Open the demo quiz →

Open demo

The Wrong Scan and the Gut

Dedicated sacroiliac imaging, Crohn’s disease, treatment selection and separate axial, bowel and skin outcomes.

Open the demo quiz →

A Taper Is a Plan, Not a Countdown

Certolizumab schedules, sustained control, a shared taper and flare plan, and radiographic category changes.

Explore the quiz →

Ready Is Not the Same as Waiting

Rehabilitation, screening, vaccines and drug-specific risks: preparation that runs alongside treatment.

Explore the quiz →

Difficult Is Not Refractory

After several drugs: drug levels, above-label dosing, dual therapy and the reason for each change.

Explore the quiz →

“Still Tired” Is Not a Measurement

Fatigue, function, follow-up intervals and drug-specific safety: what a low score leaves out.

Explore the quiz →

Pregnancy Is Not a Treatment

Preconception planning, delivery, the postpartum restart, breastfeeding and the partner’s medication.

Explore the quiz →

Open demo

Quiet Is Not Gone

Juvenile-onset SpA at transfer: the original phenotype, pediatric MRI and a handover that keeps treatment going.

Open the demo quiz →
Read the nr-axSpA clinical chapter →

CASCADE · Interactive clinical learning

Maria’s next treatment decision

Recurrent joint and skin symptoms: explore TYK2 signaling, critique a simulated trial and complete the original interactive case.

Open CSC-001 →

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: Spondyloarthritis